Healthcare Realty Trust (NYSE:HR) Updates FY25 Earnings Guidance

Healthcare Realty Trust (NYSE:HR) issued an update on its FY25 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $1.56 to $1.60 for the period, compared to the consensus earnings per share estimate of $1.59. Healthcare Realty Trust also updated its FY 2025 guidance to 1.560-1.600 EPS.

Healthcare Realty Trust Stock Performance

HR traded down $0.22 during trading on Wednesday, reaching $16.77. 3,385,673 shares of the stock were exchanged, compared to its average volume of 2,369,625. The stock has a market cap of $5.94 billion, a P/E ratio of -10.61 and a beta of 0.94. Healthcare Realty Trust has a twelve month low of $12.77 and a twelve month high of $18.90. The stock’s 50 day moving average price is $16.69 and its two-hundred day moving average price is $17.42.

Healthcare Realty Trust (NYSE:HR) last issued its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.01. The business had revenue of $309.77 million for the quarter, compared to the consensus estimate of $303.81 million. Healthcare Realty Trust had a negative net margin of 45.63% and a negative return on equity of 9.42%. The firm’s revenue for the quarter was down 6.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.39 earnings per share. Equities research analysts predict that Healthcare Realty Trust will post 1.55 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts recently weighed in on HR shares. Jefferies Financial Group downgraded shares of Healthcare Realty Trust from a “buy” rating to a “hold” rating and lowered their target price for the stock from $19.00 to $17.00 in a report on Thursday, January 2nd. Wedbush downgraded shares of Healthcare Realty Trust from a “neutral” rating to an “underperform” rating and decreased their price objective for the company from $18.00 to $16.00 in a report on Thursday, January 2nd. Finally, JPMorgan Chase & Co. downgraded shares of Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 price objective on the stock. in a report on Friday, December 20th. Two equities research analysts have rated the stock with a sell rating and four have assigned a hold rating to the company’s stock. According to data from MarketBeat, Healthcare Realty Trust presently has an average rating of “Hold” and a consensus price target of $17.00.

Insider Buying and Selling at Healthcare Realty Trust

In other Healthcare Realty Trust news, Director Thomas N. Bohjalian bought 7,750 shares of Healthcare Realty Trust stock in a transaction dated Friday, November 22nd. The stock was bought at an average price of $17.39 per share, with a total value of $134,772.50. Following the completion of the transaction, the director now owns 50,002 shares in the company, valued at $869,534.78. The trade was a 18.34 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Peter F. Sr Lyle, Sr. bought 10,000 shares of Healthcare Realty Trust stock in a transaction dated Friday, December 13th. The stock was acquired at an average cost of $17.21 per share, with a total value of $172,100.00. Following the transaction, the director now owns 26,576 shares of the company’s stock, valued at $457,372.96. This trade represents a 60.33 % increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 18,750 shares of company stock worth $323,723 over the last ninety days. Insiders own 0.56% of the company’s stock.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.